Cipla USA, Inc. recalls Albuterol Sulfate
- Published
- 27 Aug 2025
- Units affected
- 20352 packs (1x 200 MD)
- Agency
- FDA
- Country
- United States
The hazard
Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.
Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.
- Brand / company
- Cipla USA, Inc.
- Codes / lots
- Lot#: 4IB0519, Exp. 04/30/2026
- Distribution
- U.S. Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 27 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.